Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2019
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MSCaroline Lavie, Fabien Rollot, Françoise Durand-Dubief, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2020
Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: The POPARTMUS studySandra Vukusic, Iuliana Ionescu, Catherine Cornu, et al.Journal of Neurosurgery|March 17, 2017
Interactions between glioma and pregnancy: insight from a 52-case multicenter seriesSophie Peeters, Mélanie Pagès, Guillaume Gauchotte, et al.JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.JAMA Neurology|February 26, 2014
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective studyMikael Cohen, Elisabeth Maillart, Ayman Tourbah, et al.BMC Neurology|October 28, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in FranceSarah Wilson, Emmanuelle Leray, Floriane Calocer, et al.Neurology|January 31, 2016
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational studyLaetitia Barbin, Chloe Rousseau, Natacha Jousset, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod WithdrawalFabien Rollot, Justine Couturier, Romain Casey, et al.Neurology|April 27, 2018
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR studyAlvaro Cobo-Calvo, Anne Ruiz, Elisabeth Maillart, et al.European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.Pageof 8